These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24246168)

  • 1. Development of a high-throughput replicon assay for the identification of respiratory syncytial virus inhibitors.
    Tiong-Yip CL; Plant H; Sharpe P; Fan J; Rich K; Gorseth E; Yu Q
    Antiviral Res; 2014 Jan; 101():75-81. PubMed ID: 24246168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Hit Screening Cascade to Identify Respiratory Syncytial Virus (RSV) Inhibitors.
    Plant H; Stacey C; Tiong-Yip CL; Walsh J; Yu Q; Rich K
    J Biomol Screen; 2015 Jun; 20(5):597-605. PubMed ID: 25656237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W; Duggal R
    Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.
    Laganas VA; Dunn EF; McLaughlin RE; Tiong-Yip CL; Yuzhakov O; Isabella VM; Hill P; Yu Q
    Antiviral Res; 2015 Mar; 115():71-4. PubMed ID: 25542974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen.
    Duvall JR; VerPlank L; Ludeke B; McLeod SM; Lee MD; Vishwanathan K; Mulrooney CA; Le Quement S; Yu Q; Palmer MA; Fleming P; Fearns R; Foley MA; Scherer CA
    Antiviral Res; 2016 Jul; 131():19-25. PubMed ID: 27059228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
    Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
    Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
    Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
    Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
    Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
    Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
    Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
    Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
    Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
    Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phenotypic High-Throughput Screen with RSV-Infected Primary Human Small Airway Epithelial Cells (SAECs).
    Gobel J; Gartland M; Gurley SH; Kadwell S; Gillie D; Moore C; Goetz A
    J Biomol Screen; 2015 Jul; 20(6):729-38. PubMed ID: 25862685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.
    Heylen E; Neyts J; Jochmans D
    Biochem Pharmacol; 2017 Mar; 127():1-12. PubMed ID: 27659812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.
    Lundin A; Bergström T; Trybala E
    Methods Mol Biol; 2013; 1030():345-63. PubMed ID: 23821281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 replicon for high-throughput antiviral screening.
    Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.
    Liuzzi M; Mason SW; Cartier M; Lawetz C; McCollum RS; Dansereau N; Bolger G; Lapeyre N; Gaudette Y; Lagacé L; Massariol MJ; Dô F; Whitehead P; Lamarre L; Scouten E; Bordeleau J; Landry S; Rancourt J; Fazal G; Simoneau B
    J Virol; 2005 Oct; 79(20):13105-15. PubMed ID: 16189012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of respiratory syncytial virus replication in cultured cells by RNA-cleaving DNAzyme].
    Zhao CA; Zhao XD; Yu HG; Wu YP; Yang XQ
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):594-7. PubMed ID: 14744382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cells.
    Iesato K; Tatsumi K; Saito K; Ogasawara T; Sakao S; Tada Y; Kasahara Y; Kurosu K; Tanabe N; Takiguchi Y; Kuriyama T; Shirasawa H
    Respiration; 2008; 76(4):434-41. PubMed ID: 18728351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.
    Li JQ; Deng CL; Gu D; Li X; Shi L; He J; Zhang QY; Zhang B; Ye HQ
    Antiviral Res; 2018 Feb; 150():148-154. PubMed ID: 29288699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.